Okayama, Japan

Masaharu Seno

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Kadotabunkamachi Okayama, JP (2011)
  • Okayama, JP (2009 - 2020)

Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Masaharu Seno: A Pioneer in Drug Delivery Systems**

Introduction

Masaharu Seno, an innovative inventor based in Okayama, Japan, has made substantial contributions to the field of drug delivery systems. With a total of three patents to his name, his work focuses on enhancing the efficacy of therapeutic agents, particularly those used in cancer treatment. His innovative approaches are significant in reducing the side effects associated with traditional treatments.

Latest Patents

One of Seno's latest patents is titled “Method for producing liposome encapsulating paclitaxel monoglycoside and/or docetaxel monoglycoside.” This method aims to minimize the side effects of paclitaxel derivatives, known for their anti-cancer properties. Seno's technique involves creating liposomes that encapsulate paclitaxel and docetaxel monoglycosides, specifically targeting cancer cells through an antibody. The process includes contacting a liposome containing polyoxyethylene ester derivatives with a solution of the paclitaxel derivatives, providing a novel way to significantly enhance drug delivery efficiency.

Another notable patent from Seno is the creation of “Hollow nanoparticle of NBsAg large protein for drug delivery.” This invention utilizes hollow protein nanoparticles displaying antibodies that target specific cells or tissues. Animal testing has validated the effectiveness of this innovative therapeutic method, which encapsulates disease-targeting substances, such as cancer treatment genes, within the nanoparticles. By displaying cancer-specific antibodies on the particle surface, Seno's development represents a promising direction in cancer therapy.

Career Highlights

Masaharu Seno has been associated with notable organizations, including Beacle, Inc. and the Japan Science and Technology Agency. His work at these institutions has played a crucial role in advancing research in drug delivery technologies. Through these experiences, Seno has developed a robust understanding of both the scientific and practical applications of his inventions.

Collaborations

Throughout his career, Seno has collaborated with prominent figures such as Katsuyuki Tanizawa and Akihiko Kondo. These collaborations have allowed him to enhance his research through shared expertise and insights, significantly contributing to his successful patent applications.

Conclusion

Masaharu Seno stands out as a leading inventor in the field of innovative drug delivery systems. His patents not only demonstrate his commitment to improving cancer treatment but also underscore the importance of collaboration in scientific advances. As medical technology continues to evolve, the impact of Seno's inventions will likely resonate within the healthcare community, helping to shape the future of cancer therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…